Cannara Biotech 주식 가격. LOVE - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

1.08

매수가

1.07

매도가

1.10

거래량

59,284

1.05 일간 변동폭 1.10

0.00 52주 범위 0.00

market_cap

97.219M

전일 종가

1.09

개장가

1.08

최근 거래 시간

400

1.08

마지막 거래 시간

04:44:15

재정 규모

VWAP

평균 볼륨(3m)

발행 주식

90,018,000

배당수익률

주가수익률

15.10

주당순이익(EPS)

0.07

매출

82.15M

순이익

6.44M

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.cannara.ca

본부

Saint-laurent, Quebec, Can

설립됨

Cannara Biotech Inc is listed in the Pharmaceutical Preparations sector of the TSX 벤처 거래소 with ticker LOVE. The last closing price for Cannara Biotech was $1.09. Over the last year, Cannara Biotech shares have traded in a share price range of $ 0.00 to $ 0.00.

Cannara Biotech currently has 90,018,000 shares in issue. The market capitalisation of Cannara Biotech is $98.12 million. Cannara Biotech has a price to earnings ratio (PE ratio) of 15.10.

Cannara Biotech Reports Record Q1 2025 Revenue and National Market Share, Sets Stage for Continued Momentum in 2025

Record Revenue: Net revenues of $25.1 million in Q1 2025, a 29% increase compared to $19.5 million in Q1 2024, driven by strong demand for Cannara’s premium-grade cannabis products.Record Market...

Cannara Provides Update on Its 2024 Annual General Meeting Materials amid Canada Post Strike

MONTREAL, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of...

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of...

Cannara Biotech Inc. Reports Q4 and Fiscal Year 2024 Results: Achieves Record Sales Growth and Operating Cash Flow, Solidifying Leadership in Canada's Cannabis Market

Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023.Robust growth in Q4 over Q3 2024, with total...

Cannara Biotech Achieves its Highest National Market Share of 3.2% in July 2024 and Announces Investor Webcast Scheduled for August 20, 2024

MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis...

Cannara Biotech Reports Q3 2024 Financial Results

Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased...

Cannara Biotech Inc. Enters into Definitive Agreement to Acquire TGOD's State-of-the-Art Cultivation and Manufacturing Facility

Cannara Biotech Inc. Enters into Definitive Agreement to Acquire TGOD's State-of-the-Art Cultivation and Manufacturing Facility in Valleyfield, Quebec Newly built fully automated one...

Cannara Biotech Delivers Strong Q2 2021 Results

Cannara Biotech Delivers Strong Q2 2021 Results Significant second quarter revenue generation of $1.2 million and gross profit increase to $2.1 million showcases Cannara's...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

LOVE - Frequently Asked Questions (FAQ)

What is the current Cannara Biotech share price?

The current share price of Cannara Biotech is $ 1.08

How many Cannara Biotech shares are in issue?

Cannara Biotech has 90,018,000 shares in issue

What is the market cap of Cannara Biotech?

The market capitalisation of Cannara Biotech is CAD 98.12M

What is the 1 year trading range for Cannara Biotech share price?

Cannara Biotech has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Cannara Biotech?

The price to earnings ratio of Cannara Biotech is 15.1

What is the cash to sales ratio of Cannara Biotech?

The cash to sales ratio of Cannara Biotech is 1.18

What is the reporting currency for Cannara Biotech?

Cannara Biotech reports financial results in CAD

What is the latest annual turnover for Cannara Biotech?

The latest annual turnover of Cannara Biotech is CAD 82.15M

What is the latest annual profit for Cannara Biotech?

The latest annual profit of Cannara Biotech is CAD 6.44M

What is the registered address of Cannara Biotech?

The registered address for Cannara Biotech is 333 D��CARIE, SUITE 200, SAINT-LAURENT, QUEBEC, H4N 3M9

What is the Cannara Biotech website address?

The website address for Cannara Biotech is www.cannara.ca

Which industry sector does Cannara Biotech operate in?

Cannara Biotech operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
ATR.PAster Acquisition Corp	$ 0.045 (350.00%)	11k
AGH.HCanadian Silver Hunter Inc	$ 0.035 (133.33%)	11k
RAC.PRiverwalk Acquisition Corp	$ 0.03 (100.00%)	10k
ODX.HOdyssey Resources Limited	$ 0.05 (100.00%)	120k
KLXCarbon Done Right Developments Inc	$ 0.02 (100.00%)	942.5k
ALTAlturas Minerals Corp	$ 0.005 (-50.00%)	41k
TKUTarku Resources Ltd	$ 0.005 (-50.00%)	121k
TVC.HThree Valley Copper Corp	$ 0.005 (-50.00%)	57.9k
VMVoyageur Pharmaceuticals Ltd	$ 0.135 (-43.75%)	1.33M
VPIVitality Products Inc	$ 0.015 (-40.00%)	12k
ATXAtex Resources Inc	$ 1.99 (7.57%)	6.52M
NDANeptune Digital Assets Corp	$ 2.69 (23.96%)	3.07M
QNCQuantum Emotion Corp	$ 0.68 (-10.53%)	2.3M
OMGOmai Gold Mines Corp	$ 0.325 (-1.52%)	1.89M
GPUSAlset AI Ventures Inc	$ 0.105 (-4.55%)	1.87M